The Food and Drug Association (FDA) selected Air Force 2nd Lt. Tori Kinamon, MD Candidate at the Duke University School of Medicine, to receive an FDA Antibacterial Drug Resistance (DOOR) Fellowship. The one year fellowship, which begins June 2021, is with the Office of Infectious Diseases Division of Anti-infectives led by Sumanthi Nambiar, MD.
The fellowship evaluates ordinal endpoints using the Desirability of Outcome Ranking (DOOR) approach for anti-infective clinical trials for indications such as hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia (HABP/VABP), complicated urinary tract infections (cUTI), complicated intra-abdominal infections (cIAI) and acute bacterial skin and skin structure infections (ABSSSI). DOOR is an innovative approach used in clinical trials to evaluate the global benefits and risks of an intervention.
The Food and Drug Association (FDA) offers this fellowship opportunity through the Oak Ridge Institute for Science and Education (ORISE).